# Attune Pharmaceuticals, Inc. — Form D

Attune Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-29. The offering totals $23.6M, of which $23.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-06-29
- Form: D
- Accession: 0001744769-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $23.6M
- Amount sold: $23.3M
- Remaining: $265K
- Investors: 11
- Date of first sale: 2018-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315744

## Issuer

- Name: Attune Pharmaceuticals, Inc.
- CIK: 0001744769
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 250 WEST 55TH STREET, 34TH FLOOR, NEW YORK, NY, 10019
- Phone: 1-646-597-6987

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Andrew McDonald | Director | NEW YORK, NY |
| Adam Tomasi | Director | NEW YORK, NY |
| Roderick Wong | Director | New York, NY |
| Jason Bablak | Executive Officer | Pittsburgh, PA |
| Andrew McDonald | Executive Officer | NEW YORK, NY |

## More

- [CIK 1744769 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1744769&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001744769-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.